Legal & General Group PLC Ardelyx, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 260,193 shares of ARDX stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
260,193
Previous 260,193 -0.0%
Holding current value
$1.17 Million
Previous $1.79 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$5.28 - $7.57 $2,772 - $3,974
525 Added 0.2%
260,193 $1.79 Million
Q2 2024

Aug 14, 2024
BUY
$5.89 - $9.31 $146,266 - $231,195
24,833 Added 10.57%
259,668 $1.92 Million
Q1 2024

May 14, 2024
BUY
$6.05 - $9.74 $88,317 - $142,184
14,598 Added 6.63%
234,835 $1.71 Million
Q4 2023

Feb 15, 2024
BUY
$3.29 - $6.64 $73,765 - $148,875
22,421 Added 11.33%
220,237 $1.37 Million
Q3 2023

Nov 14, 2023
SELL
$3.3 - $4.83 $5,903 - $8,640
-1,789 Reduced 0.9%
197,816 $807,000
Q2 2023

Aug 14, 2023
BUY
$3.23 - $4.95 $472,742 - $724,482
146,360 Added 274.88%
199,605 $676,000
Q1 2023

May 15, 2023
BUY
$2.68 - $4.79 $142,696 - $255,043
53,245 New
53,245 $255,000
Q2 2022

Aug 22, 2022
SELL
$0.51 - $1.17 $4,259 - $9,770
-8,351 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$0.86 - $1.7 $81,312 - $160,733
-94,549 Reduced 91.88%
8,351 $9,000
Q3 2021

Nov 15, 2021
BUY
$1.27 - $8.17 $116,937 - $752,269
92,077 Added 850.75%
102,900 $136,000
Q2 2021

Aug 12, 2021
SELL
$6.55 - $8.98 $1,650 - $2,262
-252 Reduced 2.28%
10,823 $82,000
Q1 2021

May 17, 2021
SELL
$6.1 - $7.69 $2,519 - $3,175
-413 Reduced 3.6%
11,075 $73,000
Q3 2020

Nov 13, 2020
SELL
$5.25 - $7.08 $16,002 - $21,579
-3,048 Reduced 20.97%
11,488 $60,000
Q2 2020

Aug 14, 2020
BUY
$5.37 - $8.11 $36,150 - $54,596
6,732 Added 86.26%
14,536 $100,000
Q1 2020

May 14, 2020
SELL
$4.35 - $8.79 $1,592 - $3,217
-366 Reduced 4.48%
7,804 $44,000
Q3 2019

Nov 13, 2019
BUY
$2.15 - $6.28 $3,412 - $9,966
1,587 Added 24.11%
8,170 $38,000
Q3 2018

Nov 20, 2018
BUY
$3.75 - $4.65 $7,470 - $9,262
1,992 Added 43.39%
6,583 $29,000
Q2 2018

Aug 10, 2018
SELL
$3.7 - $5.8 $7,048 - $11,049
-1,905 Reduced 29.33%
4,591 $17,000
Q1 2018

May 17, 2018
SELL
$5.05 - $7.9 $12,816 - $20,050
-2,538 Reduced 28.09%
6,496 $33,000
Q4 2017

Feb 13, 2018
BUY
$4.85 - $7.8 $43,814 - $70,465
9,034
9,034 $60,000

Others Institutions Holding ARDX

# of Institutions
219
Shares Held
141M
Call Options Held
1.08M
Put Options Held
2M
View Full List

About ARDELYX, INC.

ARDX Quotes by TradingView
  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $694M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email